198 related articles for article (PubMed ID: 20201399)
1. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
[TBL] [Abstract][Full Text] [Related]
4. Present and future therapeutic strategies for melioidosis and glanders.
Estes DM; Dow SW; Schweizer HP; Torres AG
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):325-38. PubMed ID: 20192686
[TBL] [Abstract][Full Text] [Related]
5. Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.
Gilad J
Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):233-41. PubMed ID: 18221181
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance in Burkholderia species.
Rhodes KA; Schweizer HP
Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
[TBL] [Abstract][Full Text] [Related]
7. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
McLaughlin HP; Sue D
BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
Jenney AW; Lum G; Fisher DA; Currie BJ
Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
Barnes KB; Steward J; Thwaite JE; Lever MS; Davies CH; Armstrong SJ; Laws TR; Roughley N; Harding SV; Atkins TP; Simpson AJ; Atkins HS
Int J Antimicrob Agents; 2013 Jun; 41(6):552-7. PubMed ID: 23517714
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study on chemotherapy of acute glanders].
Iliukhin VI; Rotov KA; Senina TV; Snatenkov EA; Tikhonov SN; Plekhanova NG; Kulikova AS; Shubnikova EV; Korol' EV; Nekhezina MO
Antibiot Khimioter; 2012; 57(11-12):11-5. PubMed ID: 23700931
[TBL] [Abstract][Full Text] [Related]
11. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010.
Lipsitz R; Garges S; Aurigemma R; Baccam P; Blaney DD; Cheng AC; Currie BJ; Dance D; Gee JE; Larsen J; Limmathurotsakul D; Morrow MG; Norton R; O'Mara E; Peacock SJ; Pesik N; Rogers LP; Schweizer HP; Steinmetz I; Tan G; Tan P; Wiersinga WJ; Wuthiekanun V; Smith TL
Emerg Infect Dis; 2012 Dec; 18(12):e2. PubMed ID: 23171644
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
Maloney S; Engler C; Norton R
J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
Nhung PH; Van VH; Anh NQ; Phuong DM
J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.
Kenny DJ; Russell P; Rogers D; Eley SM; Titball RW
Antimicrob Agents Chemother; 1999 Nov; 43(11):2773-5. PubMed ID: 10543761
[TBL] [Abstract][Full Text] [Related]
15. [Fluoroquinolones: antimicrobial activity and chemotherapeutic efficacy with respect to various pathogens in highly dangerous diseases].
Bondareva TA; Kalininskiĭ VB; Borisevich IV; Bondarev VP; Kozhukhov VV; Amosov MIu; Baramzina GV; Fomenkov OO; Krinitsyn FV
Antibiot Khimioter; 2007; 52(11-12):21-4. PubMed ID: 19275053
[TBL] [Abstract][Full Text] [Related]
16. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
17. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
18. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
19.
Papp-Wallace KM; Shapiro AB; Becka SA; Zeiser ET; LiPuma JJ; Lane DJ; Panchal RG; Mueller JP; O'Donnell JP; Miller AA
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318017
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.
Judy BM; Whitlock GC; Torres AG; Estes DM
BMC Microbiol; 2009 May; 9():88. PubMed ID: 19426516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]